CVS Health Corporation
CVS
$73.15
$1.011.40%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -36.98% | -27.88% | -44.70% | -41.89% | 142.50% |
| Total Depreciation and Amortization | 1.82% | 2.44% | 5.29% | 7.23% | 8.38% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -73.89% | -85.87% | -130.39% | -35.44% | -84.53% |
| Change in Net Operating Assets | 57.50% | 8.92% | 626.67% | -1,692.24% | -132.74% |
| Cash from Operations | -6.24% | -19.57% | -32.17% | -67.32% | -60.66% |
| Capital Expenditure | 0.39% | -2.43% | 8.25% | -4.13% | 1.55% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 23.70% | 99.06% | 99.43% | 98.76% | 98.72% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -0.33% | -55.11% | -280.18% | -355.50% | -134.05% |
| Cash from Investing | 0.91% | 56.59% | 63.55% | 57.97% | 71.05% |
| Total Debt Issued | 39.31% | -42.26% | -38.92% | -63.78% | -75.39% |
| Total Debt Repaid | -227.85% | 18.73% | 41.55% | 72.41% | 82.93% |
| Issuance of Common Stock | -15.84% | -21.35% | 30.32% | 33.22% | 19.20% |
| Repurchase of Common Stock | 95.86% | 94.97% | -46.28% | 13.76% | 13.85% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.84% | -5.64% | -7.69% | -7.88% | -7.85% |
| Other Financing Activities | 110.00% | 133.96% | 112.94% | 92.35% | -80.33% |
| Cash from Financing | 26.43% | -76.38% | -142.30% | -272.89% | -485.11% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 39.17% | 104.93% | 107.51% | -48.88% | -178.55% |